Ixifi

Active Ingredient(s): Infliximab-qbtx
FDA Approved: * December 13, 2017
Pharm Company: * PFIZER INC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ixifi Overview

Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.[2] It is given by slow injection into a vein, typically at six- to eight-week intervals.[2] Common side effects include infections, acute infusion reacti...

Read more Ixifi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Infliximab

Recent Ixifi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Infliximab-qbtx
  • Injection: 100mg, 100mg/vial
  • Vial: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Infliximab-qbtx or a similar ingredient: (8 results)